Spire Healthcare Group (LON:SPI) Trading Down 15.9% – Here’s Why

Posted by Jeff Wilder on Dec 3rd, 2025

Spire Healthcare Group plc (LON:SPI – Get Free Report) shares were down 15.9% during trading on Wednesday . The company traded as low as GBX 187.20 and last traded at GBX 188. Approximately 27,846,943 shares traded hands during mid-day trading, an increase of 1,705% from the average daily volume of 1,542,760 shares. The stock had previously closed at GBX 223.50.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. decreased their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating on the stock in a research note on Tuesday, August 5th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of GBX 294.33.

Read Our Latest Stock Analysis on Spire Healthcare Group

Spire Healthcare Group Trading Down 15.9%

The stock has a market cap of £756.46 million, a price-to-earnings ratio of 40.87, a PEG ratio of 1.06 and a beta of 0.96. The company’s fifty day moving average is GBX 234.27 and its two-hundred day moving average is GBX 222.02. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group Company Profile

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.